✦ LIBER ✦

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

✍ Scribed by Laurent Pierot; Claire Desnos; Jerome Blin; Rita Raisman; Daniel Scherman; France Javoy-Agid; Merle Ruberg; Yves Agid

Book ID: 118930562
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 882 KB
Volume: 86
Category: Article
ISSN: 0022-510X
DOI: 10.1016/0022-510x(88)90106-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine D1 and D2 receptors in progress

Dopamine D1 and D2 receptors in progressive supranuclear palsy: An autoradiographic study

✍ Dr. J. Pascual; J. Berciano; B. Grijalba; E del Olmo; A. M. González; J. Figols; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Comparison of Striatal Dopamine D2 Recep

Comparison of Striatal Dopamine D2 Receptors in Parkinson's Disease and Progressive Supranuclear Palsy Patients Using [123I] Iodobenzofuran Single-Photon Emission Computed Tomography

✍ Chisako Oyanagi; Yukinori Katsumi; Takashi Hanakawa; Takuya Hayashi; Din ha Duy 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Decrease of serotonin-S2 receptors in te

Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy

✍ Dr. J. M. Maloteaux; E. C. Laterre; P. M. Laduron; F. Javoy-Agid; Y. Agid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

The number of serotonin-S, receptors was decreased in the temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy (PSP). There was no significant modification of these receptors in the frontal cortex or in the hippocampus and putamen in both diseases. The decrease in

The external globus pallidus in patients

The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy

✍ Craig D. Hardman; Glenda M. Halliday 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

Cutaneous sympathetic function and cardi

Cutaneous sympathetic function and cardiovascular function in patients with progressive supranuclear palsy and Parkinson's disease

✍ Yuriko Kikkawa; Masato Asahina; Atsuya Suzuki; Takamichi Hattori 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Striatal D2 receptor status in patients

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

✍ Dr D. J. Brooks; V. Ibanez; G. V. Sawle; E. D. Playford; N. Quinn; C. J. Mathias 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 947 KB